GO:0004029 aldehyde dehydrogenase (NAD+) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004029 describes the molecular function of aldehyde dehydrogenase (NAD+) activity, catalyzing the NAD+-dependent oxidation of an aldehyde to a carboxylate.
• The reaction consumes water and NAD+ and produces a carboxylate, two protons, and NADH, linking aldehyde detoxification to cellular redox balance.
• ALDH7A1 is a key enzyme with this activity; its NADH-generating function protects cells from ferroptosis by supporting FSP1-mediated membrane redox cycling.
• NAD+ binding promotes assembly of the active ALDH7A1 tetramer, showing that cofactor availability directly regulates enzyme activity.
• Aldehyde dehydrogenase (NAD+) activity is relevant to Parkinson's disease redox mechanisms, alcoholic liver disease, and microbial aldehyde metabolism.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of ALDH genes in disease and metabolic pathways.
Description
Aldehyde dehydrogenase (NAD+) activity (GO:0004029) is a molecular function that catalyzes the oxidation of aldehydes to carboxylic acids using NAD+ as the electron acceptor. This activity is central to aldehyde detoxification, cellular redox homeostasis, and the generation of NADH, a key reducing equivalent. Enzymes with this activity are found across species, from human ALDH7A1 to bacterial aldehyde dehydrogenases involved in glycerol dissimilation. Because aldehydes are reactive and can damage proteins, lipids, and DNA, efficient aldehyde clearance is critical for cell survival. The reaction also contributes to metabolic pathways such as acetate production by gut bacteria and synthetic cascade biomanufacturing. Researchers study GO:0004029 to understand how cells manage oxidative stress, how NAD+ availability controls enzyme assembly, and how mutations in aldehyde dehydrogenases contribute to disease.
aldehyde dehydrogenase (NAD+) activity At A Glance
| GO ID | GO:0004029 |
|---|---|
| GO term | aldehyde dehydrogenase (NAD+) activity |
| Ontology | molecular_function |
| Synonym | NAD-dependent aldehyde dehydrogenase activity; aldehyde:NAD+ oxidoreductase activity; CoA-independent aldehyde dehydrogenase activity; propionaldehyde dehydrogenase activity |
| Major function | Catalyzes the NAD+-dependent oxidation of an aldehyde to a carboxylate, producing NADH and protons |
| Reaction | an aldehyde + H2O + NAD+ = a carboxylate + 2 H+ + NADH |
| Cofactor | NAD+ is required for catalysis and promotes assembly of active ALDH7A1 tetramers |
| Representative enzyme | ALDH7A1, which generates membrane NADH and regulates FSP1 to protect against ferroptosis |
| Related disease area | Parkinson's disease redox mechanisms, alcoholic liver disease, and microbial aldehyde metabolism |
What Is GO:0004029?
GO:0004029 aldehyde dehydrogenase (NAD+) activity is defined as catalysis of the reaction: an aldehyde + H2O + NAD+ = a carboxylate + 2 H+ + NADH. In other words, the enzyme uses NAD+ to oxidize an aldehyde substrate, releasing a carboxylic acid and generating NADH. This activity is synonymous with NAD-dependent aldehyde dehydrogenase activity, CoA-independent aldehyde dehydrogenase activity, and several substrate-specific names such as propionaldehyde dehydrogenase activity. The function is classified under the molecular_function aspect of the Gene Ontology.
Why Is aldehyde dehydrogenase (NAD+) activity Important in Cell Biology?
Aldehyde dehydrogenase (NAD+) activity is important because it controls the levels of reactive aldehydes and simultaneously produces NADH, a major cellular reducing agent. This dual role links the function to ferroptosis suppression, redox signaling, and metabolic flux. In humans, impaired aldehyde dehydrogenase activity has been associated with Parkinson's disease redox mechanisms and alcoholic liver disease, where aldehyde accumulation contributes to oxidative stress. In microbes, the same activity supports acetate production and glycerol dissimilation, with biotechnological relevance. Understanding GO:0004029 therefore spans human disease, microbiology, and synthetic biology.
• Protects cells from ferroptosis by generating membrane NADH that supports FSP1-mediated redox cycling.
• NAD+ binding drives assembly of the active ALDH7A1 tetramer, linking cofactor availability to enzyme function.
• Contributes to Parkinson's disease redox mechanisms through aldehyde detoxification and NADH production.
• Supports acetate production by aerobic bacteria of the human large intestine.
• Enables enhanced aldehyde dehydrogenase activity in Klebsiella pneumoniae for glycerol dissimilation.
• Is a target for restoring ALDH2 function in alcoholic liver disease, as shown with formononetin.
• Provides a model for directed evolution of thermostable aldehyde dehydrogenases in synthetic cascade biomanufacturing.
• Can be studied alongside aldehyde dismutase activity of human liver alcohol dehydrogenase, which also consumes aldehydes.
Molecular Mechanism of aldehyde dehydrogenase (NAD+) activity
Substrate binding and NAD+ cofactor interaction
In simple terms: The enzyme grabs an aldehyde and a NAD+ molecule to start the reaction.
Aldehyde dehydrogenase (NAD+) activity requires binding of both an aldehyde substrate and the NAD+ cofactor. NAD+ is not only an electron acceptor but also promotes assembly of the active tetramer of ALDH7A1, indicating that cofactor binding is coupled to quaternary structure. This step ensures that catalysis occurs only when NAD+ is available, linking enzyme activity to cellular redox status.
Catalytic oxidation and NADH generation
In simple terms: The enzyme removes electrons from the aldehyde and hands them to NAD+, making NADH.
The catalytic reaction converts an aldehyde, water, and NAD+ into a carboxylate, two protons, and NADH. This oxidation step detoxifies the aldehyde and generates NADH, which can be used in membrane redox reactions. In ALDH7A1, the NADH produced at membranes supports FSP1 function and protects against ferroptosis.
Tetramer assembly and active site formation
In simple terms: The enzyme must assemble into a four-part complex to work properly.
NAD+ promotes assembly of the active tetramer of aldehyde dehydrogenase 7A1. This assembly step is essential because the active site is formed at the interface of subunits, and without NAD+ the enzyme remains in a less active state. The tetrameric organization also provides structural stability for sustained catalytic turnover.
Membrane NADH production and ferroptosis protection
In simple terms: The NADH made by this enzyme at membranes helps stop a type of cell death called ferroptosis.
ALDH7A1 generates membrane NADH and regulates FSP1, which acts as a ferroptosis suppressor. By maintaining reduced coenzyme Q and preventing lipid peroxidation, this pathway protects cells from ferroptosis. This mechanism links GO:0004029 directly to a non-apoptotic cell death pathway.
Aldehyde detoxification in disease and microbial metabolism
In simple terms: The same enzyme activity clears harmful aldehydes in the body and in bacteria.
In Parkinson's disease, redox mechanisms involving aldehyde detoxification are thought to contribute to neuronal vulnerability. In alcoholic liver disease, restoring ALDH2 function mitigates injury through ERK1/2-Nrf2 antioxidant signaling. In bacteria, aldehyde dehydrogenase activity supports acetate production and glycerol dissimilation. These examples show the broad biological reach of GO:0004029.
Key Genes Involved in GO:0004029 aldehyde dehydrogenase (NAD+) activity
The following genes and proteins are experimentally linked to aldehyde dehydrogenase (NAD+) activity or its physiological context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ALDH7A1 | Generates membrane NADH and regulates FSP1 to protect against ferroptosis | Central to ferroptosis research and NADH-dependent redox biology |
| ALDH2 | Aldehyde dehydrogenase involved in alcohol metabolism and antioxidant signaling | Target for alcoholic liver disease and ERK1/2-Nrf2 signaling studies |
| ALDH1A1 | Cytosolic aldehyde dehydrogenase with NAD+ activity | Model enzyme for studying GO:0004029 in cancer and stem cells |
| ALDH1B1 | Mitochondrial aldehyde dehydrogenase | Relevant to aldehyde detoxification and metabolic stress |
| ALDH3A1 | Aldehyde dehydrogenase with broad substrate specificity | Studied in oxidative stress protection |
| ALDH5A1 | Succinic semialdehyde dehydrogenase | Links GO:0004029 to GABA metabolism |
| ALDH6A1 | Methylmalonate-semialdehyde dehydrogenase | Involved in valine and pyrimidine catabolism |
| ALDH7A1 (bacterial homolog) | Aldehyde dehydrogenase in Klebsiella pneumoniae | Used to enhance glycerol dissimilation |
| Aldehyde dehydrogenase (thermostable) | Directed evolution for synthetic cascade biomanufacturing | Biocatalyst engineering |
| Alcohol dehydrogenase | Aldehyde dismutase activity in human liver | Related aldehyde-consuming activity |
| FSP1 | Ferroptosis suppressor regulated by ALDH7A1-derived NADH | Downstream effector of GO:0004029 |
| Nrf2 | Antioxidant transcription factor induced by ERK1/2 signaling | Mediates protective effects of restored ALDH2 |
| ERK1/2 | Kinase pathway upstream of Nrf2 in alcoholic liver disease | Signaling node linked to ALDH2 function |
| Gut bacterial aldehyde dehydrogenases | Acetate production in human large intestine | Microbiome metabolism studies |
| Klebsiella pneumoniae aldehyde dehydrogenase | Glycerol dissimilation | Industrial microbiology |
| Human liver alcohol dehydrogenase | Aldehyde dismutase activity | Comparative aldehyde metabolism |
| ALDH7A1 tetramer | Active quaternary structure promoted by NAD+ | Structural and biochemical studies |
How Is aldehyde dehydrogenase (NAD+) activity Regulated?
Aldehyde dehydrogenase (NAD+) activity is regulated at multiple levels. NAD+ availability directly promotes assembly of the active ALDH7A1 tetramer, so changes in cellular NAD+ levels can control enzyme activity. In alcoholic liver disease, restoring ALDH2 function is accompanied by induction of ERK1/2-Nrf2 antioxidant signaling, indicating that ALDH2 activity is integrated with stress-responsive transcriptional programs. In bacteria, aldehyde dehydrogenase activity can be enhanced by regenerating NAD+, linking cofactor supply to flux through glycerol dissimilation pathways. These examples show that regulation occurs through cofactor availability, protein assembly, and signaling pathways.
aldehyde dehydrogenase (NAD+) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALDH7A1 | Ferroptosis suppression via membrane NADH and FSP1 | ALDH7A1 knockout and overexpression cell lines |
| ALDH2 | Alcoholic liver disease and ERK1/2-Nrf2 signaling | ALDH2 point-mutation or knockout hepatocytes |
| ALDH2 | Parkinson's disease redox mechanisms | Neuronal cell models with ALDH2 modulation |
| Gut bacterial ALDH | Acetate production in large intestine | Anaerobic bacterial culture models |
| Klebsiella pneumoniae ALDH | Glycerol dissimilation | Bacterial knockout and NAD+ regeneration models |
Aldehyde dehydrogenase (NAD+) activity and Parkinson's disease
Parkinson's disease involves redox mechanisms in which aldehyde accumulation and oxidative stress contribute to neuronal dysfunction. Aldehyde dehydrogenase (NAD+) activity supports detoxification of reactive aldehydes and generation of NADH, which may help buffer oxidative damage. Although direct causal links require further study, the redox biology of GO:0004029 is relevant to neurodegeneration research.
Aldehyde dehydrogenase (NAD+) activity and alcoholic liver disease
In alcoholic liver disease, impaired ALDH2 function leads to aldehyde accumulation and liver injury. Formononetin mitigates alcoholic liver disease by restoring ALDH2 function and inducing ERK1/2-Nrf2 antioxidant signaling. This demonstrates that pharmacological restoration of aldehyde dehydrogenase activity can be protective.
Aldehyde dehydrogenase (NAD+) activity and ferroptosis
ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1. This places GO:0004029 at the center of a non-apoptotic cell death pathway that is relevant to cancer, neurodegeneration, and ischemia-reperfusion injury. Targeting this activity could modulate ferroptosis sensitivity.
Aldehyde dehydrogenase (NAD+) activity in microbial and metabolic contexts
Aldehyde dehydrogenase activity in gut bacteria contributes to acetate production, influencing host-microbe metabolism. In Klebsiella pneumoniae, enhanced aldehyde dehydrogenase activity supports glycerol dissimilation, with implications for industrial biotechnology. These microbial systems provide tractable models for studying GO:0004029.
From aldehyde dehydrogenase (NAD+) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ALDH7A1 increase ferroptosis sensitivity? | ALDH7A1 knockout cell line |
| Does NAD+ promote ALDH7A1 tetramer assembly? | Purified protein with NAD+ titration and structural analysis |
| Can restoring ALDH2 function protect against alcoholic liver disease? | ALDH2 point-mutation or overexpression hepatocyte model |
| Does enhanced aldehyde dehydrogenase activity improve glycerol dissimilation? | Klebsiella pneumoniae overexpression strain |
| Can directed evolution improve thermostable aldehyde dehydrogenase? | Bacterial expression and screening library |
| Does aldehyde dehydrogenase activity affect acetate production? | Gut bacterial knockout or overexpression |
How to Study the aldehyde dehydrogenase (NAD+) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADH absorbance assay | Aldehyde dehydrogenase (NAD+) activity | Enzyme kinetics and inhibitor testing |
| Size-exclusion chromatography | Tetramer assembly promoted by NAD+ | Structural characterization of ALDH7A1 |
| Lipid peroxidation assay | Ferroptosis sensitivity | ALDH7A1 knockout vs. wild-type cells |
| NADH biosensor imaging | Membrane NADH levels | Live-cell redox imaging |
| Directed evolution screening | Improved thermostable aldehyde dehydrogenase | Biocatalyst engineering |
| Glycerol dissimilation assay | Bacterial aldehyde dehydrogenase flux | Klebsiella pneumoniae metabolic engineering |
| Acetate production measurement | Gut bacterial aldehyde dehydrogenase activity | Microbiome metabolism studies |
| ERK1/2-Nrf2 signaling assay | Antioxidant pathway activation | Alcoholic liver disease models |
Enzymatic activity assays
Aldehyde dehydrogenase (NAD+) activity can be measured spectrophotometrically by monitoring NADH production at 340 nm. Such assays are used to confirm that ALDH7A1 or other enzymes catalyze the reaction and to test the effect of NAD+ availability. Activity assays are also used in directed evolution campaigns to identify improved thermostable variants.
Structural and biophysical methods
NAD+ promotes assembly of the active ALDH7A1 tetramer, which can be studied by size-exclusion chromatography, analytical ultracentrifugation, or native mass spectrometry. These methods reveal how cofactor binding changes oligomeric state and activity. Structural studies help define the catalytic mechanism of GO:0004029.
Cell-based ferroptosis and redox assays
ALDH7A1-dependent ferroptosis protection can be assessed using lipid peroxidation probes, viability assays, and FSP1 functional readouts. Membrane NADH levels can be measured with genetically encoded sensors or biochemical fractionation. These approaches link GO:0004029 to cell death pathways.
Microbial and metabolic engineering methods
Bacterial aldehyde dehydrogenase activity can be enhanced by regenerating NAD+ and monitoring glycerol dissimilation or acetate production. Directed evolution and screening of aldehyde dehydrogenase libraries support synthetic cascade biomanufacturing. These methods provide scalable systems for studying GO:0004029.
How CRISPR Can Be Used to Study GO:0004029 aldehyde dehydrogenase (NAD+) activity
Knockout
CRISPR knockout of ALDH7A1 or ALDH2 can eliminate aldehyde dehydrogenase (NAD+) activity, enabling loss-of-function studies. Knockout cells are useful for testing ferroptosis sensitivity, aldehyde accumulation, and metabolic flux. Such models provide causal evidence for the role of GO:0004029 in disease.
Point Mutation
Point mutations in ALDH2 or ALDH7A1 can mimic disease-associated variants or disrupt catalytic residues. These models help dissect how specific amino acids contribute to NAD+ binding, tetramer assembly, and catalysis. They are valuable for testing pharmacological rescue strategies.
Knock-in
Knock-in of tagged or fluorescent ALDH7A1 allows tracking of protein localization and interaction with FSP1. Knock-in of disease-relevant mutations can recreate human phenotypes in isogenic cell lines. These models support precise structure-function studies of GO:0004029.
Overexpression
Overexpression of ALDH2 or ALDH7A1 can boost aldehyde dehydrogenase (NAD+) activity and protect against oxidative stress or ferroptosis. Overexpression in bacteria can enhance glycerol dissimilation and acetate production. These gain-of-function models complement knockout studies.
How EDITGENE Supports aldehyde dehydrogenase (NAD+) activity Research
Researchers studying aldehyde dehydrogenase (NAD+) activity-related genes often need to determine whether a candidate gene is causally involved in aldehyde detoxification, ferroptosis suppression, or metabolic flux. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly.
Contact EDITGENE today to design your custom CRISPR model for aldehyde dehydrogenase (NAD+) activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ALDH1A1 Knockout HEK293 Cell Line | EDJ-KQ2024 | Human | 216 | Details Get a Quote |
| ALDH3B2 Knockout HEK293 Cell Line | EDJ-KQ2545 | Human | 222 | Details Get a Quote |
| ALDH3A1 Knockout HEK293 Cell Line | EDJ-KQ3442 | Human | 218 | Details Get a Quote |
| ALDH1A3 Knockout HEK293 Cell Line | EDJ-KQ4033 | Human | 220 | Details Get a Quote |
| ALDH1B1 Knockout HEK293 Cell Line | EDJ-KQ4035 | Human | 219 | Details Get a Quote |
| ALDH9A1 Knockout HEK293 Cell Line | EDJ-KQ4037 | Human | 223 | Details Get a Quote |
| ALDH3B1 Knockout HEK293 Cell Line | EDJ-KQ4039 | Human | 221 | Details Get a Quote |
| ALDH3A2 Knockout HEK293 Cell Line | EDJ-KQ4041 | Human | 224 | Details Get a Quote |
| ALDH7A1 Knockout HEK293 Cell Line | EDJ-KQ4111 | Human | 501 | Details Get a Quote |
| ALDH4A1 Knockout HEK293 Cell Line | EDJ-KQ6319 | Human | 8659 | Details Get a Quote |
| ALDH1A2 Knockout HEK293 Cell Line | EDJ-KQ6383 | Human | 8854 | Details Get a Quote |
| ALDH1L1 Knockout HEK293 Cell Line | EDJ-KQ7186 | Human | 10840 | Details Get a Quote |
| ALDH16A1 Knockout HEK293 Cell Line | EDJ-KQ8862 | Human | 126133 | Details Get a Quote |
| ALDH1L2 Knockout HEK293 Cell Line | EDJ-KQ12327 | Human | 160428 | Details Get a Quote |
| ALDH2 Knockout HEK293 Cell Line | EDJ-KQ12328 | Human | 217 | Details Get a Quote |
Displaying Records 1 To 15 Of 62 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About aldehyde dehydrogenase (NAD+) activity
What is aldehyde dehydrogenase (NAD+) activity?
It is a molecular function defined by GO:0004029 that catalyzes the reaction: an aldehyde + H2O + NAD+ = a carboxylate + 2 H+ + NADH.
What genes are involved in aldehyde dehydrogenase (NAD+) activity?
Key genes include ALDH7A1, ALDH2, ALDH1A1, ALDH1B1, ALDH3A1, ALDH5A1, and ALDH6A1, among others.
What is the GO ID for aldehyde dehydrogenase (NAD+) activity?
The GO ID is GO:0004029.
How does ALDH7A1 protect against ferroptosis?
ALDH7A1 generates membrane NADH and regulates FSP1, which suppresses lipid peroxidation and ferroptosis.
Does NAD+ regulate aldehyde dehydrogenase activity?
Yes, NAD+ promotes assembly of the active tetramer of ALDH7A1, linking cofactor availability to enzyme activity.
Is aldehyde dehydrogenase (NAD+) activity involved in Parkinson's disease?
Redox mechanisms involving aldehyde detoxification have been implicated in Parkinson's disease.
Can aldehyde dehydrogenase activity be restored in alcoholic liver disease?
Formononetin mitigates alcoholic liver disease by restoring ALDH2 function and inducing ERK1/2-Nrf2 signaling.
Do gut bacteria have aldehyde dehydrogenase (NAD+) activity?
Yes, aerobic bacteria of the human large intestine show aldehyde dehydrogenase activity and produce acetate.
How is aldehyde dehydrogenase (NAD+) activity measured?
It is commonly measured by NADH production in spectrophotometric assays.
What CRISPR models are used to study aldehyde dehydrogenase (NAD+) activity?
Knockout, point-mutation, knock-in, and overexpression models of ALDH genes are used to test causal roles.
Conclusion
Aldehyde dehydrogenase (NAD+) activity (GO:0004029) is a fundamental molecular function that detoxifies aldehydes while generating NADH, with critical roles in ferroptosis suppression, redox signaling, and metabolic pathways. Its importance spans human diseases such as Parkinson's disease and alcoholic liver disease, as well as microbial and industrial biotechnology. CRISPR-based models and enzymatic assays provide robust tools to dissect its mechanism and therapeutic potential.
References
- 1. Yang JS et al.. 2025. ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1.. Cell 188(10):2569-2585.e20 PMID: 40233740
- 2. Korasick DA et al.. 2018. NAD(+) promotes assembly of the active tetramer of aldehyde dehydrogenase 7A1.. FEBS Lett 592(19):3229-3238 PMID: 30184263
- 3. Adams JD Jr et al.. 2001. Parkinson's disease--redox mechanisms.. Curr Med Chem 8(7):809-14 PMID: 11375751
- 4. Nosova T et al.. 1996. Aldehyde dehydrogenase activity and acetate production by aerobic bacteria representing the normal flora of human large intestine.. Alcohol Alcohol 31(6):555-64 PMID: 9010546
- 5. Li Y et al.. 2013. Enhanced aldehyde dehydrogenase activity by regenerating NAD+ in Klebsiella pneumoniae and implications for the glycerol dissimilation pathways.. Biotechnol Lett 35(10):1609-15 PMID: 23794046
- 6. Ma Z et al.. 2025. Formononetin mitigates alcoholic liver disease by restoring ALDH2 function and inducing ERK1/2-Nrf2 antioxidant signaling.. Phytomedicine 148:157408 PMID: 41110354
- 7. Svensson S et al.. 1996. Aldehyde dismutase activity of human liver alcohol dehydrogenase.. FEBS Lett 394(2):217-20 PMID: 8843167
- 8. Steffler F et al.. 2013. Improvement of thermostable aldehyde dehydrogenase by directed evolution for application in Synthetic Cascade Biomanufacturing.. Enzyme Microb Technol 53(5):307-14 PMID: 24034429
